Published in Oncotarget on April 05, 2016
Vemurafenib-resistant BRAF-V600E-mutated melanoma is regressed by MEK-targeting drug trametinib, but not cobimetinib in a patient-derived orthotopic xenograft (PDOX) mouse model. Oncotarget (2016) 0.89
Signaling Pathways in Melanogenesis. Int J Mol Sci (2016) 0.87
Tumor-targeting Salmonella typhimurium A1-R combined with temozolomide regresses malignant melanoma with a BRAF-V600E mutation in a patient-derived orthotopic xenograft (PDOX) model. Oncotarget (2016) 0.85
RORα and RORγ expression inversely correlates with human melanoma progression. Oncotarget (2016) 0.79
PD-1 Antibody Monotherapy for Malignant Melanoma: A Systematic Review and Meta-Analysis. PLoS One (2016) 0.78
Effects of Ganodermanondiol, a New Melanogenesis Inhibitor from the Medicinal Mushroom Ganoderma lucidum. Int J Mol Sci (2016) 0.77
Comparison of the Lonidamine Potentiated Effect of Nitrogen Mustard Alkylating Agents on the Systemic Treatment of DB-1 Human Melanoma Xenografts in Mice. PLoS One (2016) 0.76
Salmonella typhimurium A1-R targeting of a chemotherapy resistant BRAF-V600E melanoma in a patient-derived orthotopic xenograft (PDOX) model is enhanced in combination with either vemurafenib-temozlomide. Cell Cycle (2017) 0.76
Deep-proteome mapping of WM-266-4 human metastatic melanoma cells: From oncogenic addiction to druggable targets. PLoS One (2017) 0.75
Vitamin D signaling and melanoma: role of vitamin D and its receptors in melanoma progression and management. Lab Invest (2017) 0.75
Gomisin N Inhibits Melanogenesis through Regulating the PI3K/Akt and MAPK/ERK Signaling Pathways in Melanocytes. Int J Mol Sci (2017) 0.75
Clinical Characteristics of Malignant Melanoma in Southwest China: A Single-Center Series of 82 Consecutive Cases and a Meta-Analysis of 958 Reported Cases. PLoS One (2016) 0.75
Characterization of the Methylthioadenosine Phosphorylase Polymorphism rs7023954 - Incidence and Effects on Enzymatic Function in Malignant Melanoma. PLoS One (2016) 0.75
Combined regimen of photodynamic therapy mediated by Gallium phthalocyanine chloride and Metformin enhances anti-melanoma efficacy. PLoS One (2017) 0.75
Patient-Derived Orthotopic Xenograft (PDOX) Models of Melanoma. Int J Mol Sci (2017) 0.75
Melanoma. N Engl J Med (2006) 8.80
Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol Rev (2004) 5.89
The multiple uses of fluorescent proteins to visualize cancer in vivo. Nat Rev Cancer (2005) 5.83
Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: a bridge to the clinic. Invest New Drugs (1999) 4.32
The physical and chemical properties of eumelanin. Pigment Cell Res (2006) 2.53
L-tyrosine and L-dihydroxyphenylalanine as hormone-like regulators of melanocyte functions. Pigment Cell Melanoma Res (2011) 2.07
Thin primary cutaneous malignant melanoma: a prognostic tree for 10-year metastasis is more accurate than American Joint Committee on Cancer staging. J Clin Oncol (2004) 1.90
Inhibitors of melanogenesis increase toxicity of cyclophosphamide and lymphocytes against melanoma cells. Int J Cancer (2009) 1.70
What are melanocytes really doing all day long...? Exp Dermatol (2009) 1.65
Melanoma resistance: a bright future for academicians and a challenge for patient advocates. Mayo Clin Proc (2014) 1.57
Patient-derived orthotopic xenografts: better mimic of metastasis than subcutaneous xenografts. Nat Rev Cancer (2015) 1.54
Hypoxia and radiation therapy: past history, ongoing research, and future promise. Curr Mol Med (2009) 1.50
Melanogenesis affects overall and disease-free survival in patients with stage III and IV melanoma. Hum Pathol (2013) 1.50
The role of melanogenesis in regulation of melanoma behavior: melanogenesis leads to stimulation of HIF-1α expression and HIF-dependent attendant pathways. Arch Biochem Biophys (2014) 1.36
High basal NF-κB activity in nonpigmented melanoma cells is associated with an enhanced sensitivity to vitamin D3 derivatives. Br J Cancer (2011) 1.35
The role of hypoxia-inducible factors in cancer. Cell Mol Life Sci (2007) 1.33
Molecular diagnostics in melanoma. J Am Acad Dermatol (2005) 1.33
Inhibition of melanogenesis as a radiation sensitizer for melanoma therapy. Int J Cancer (2008) 1.33
Emerging trends in the epidemiology of melanoma. Br J Dermatol (2014) 1.31
Inhibition of melanogenesis as an adjuvant strategy in the treatment of melanotic melanomas: selective review and hypothesis. Anticancer Res (1999) 1.29
Properties and function of the ocular melanin--a photobiophysical view. J Photochem Photobiol B (1992) 1.27
Lessons from tumor progression: the invasive radial growth phase of melanoma is common, incapable of metastasis, and indolent. J Invest Dermatol (1993) 1.23
Why do melanomas get so dark? Exp Dermatol (2009) 1.16
Genetically fluorescent melanoma bone and organ metastasis models. Clin Cancer Res (1999) 1.12
New perspectives on melanoma pathogenesis and chemoprevention. Recent Results Cancer Res (2007) 1.08
GSK3beta inhibition promotes melanogenesis in mouse B16 melanoma cells and normal human melanocytes. Cell Signal (2008) 1.06
Malignant melanoma. Arch Pathol Lab Med (2001) 1.04
The role of melanin pigment in melanoma. Exp Dermatol (2015) 1.03
Melanins, melanogenesis and melanocytes: looking at their functional significance from the chemist's viewpoint. Pigment Cell Res (2000) 0.99
Resistance of human melanoma cells to ultraviolet radiation. Cancer Res (1976) 0.93
Physico-chemical evaluation of rationally designed melanins as novel nature-inspired radioprotectors. PLoS One (2009) 0.93
Melanins and melanogenesis: from pigment cells to human health and technological applications. Pigment Cell Melanoma Res (2015) 0.92
The degree of pigmentation modulates the radiosensitivity of human melanoma cells. Radiat Res (2000) 0.88
Cell elasticity is an important indicator of the metastatic phenotype of melanoma cells. Exp Dermatol (2014) 0.88
Metabolic characterization of three hamster melanoma variants. Neoplasma (1985) 0.86
Tumor hypoxia and metabolism -- towards novel anticancer approaches. Ann Endocrinol (Paris) (2013) 0.86
Biochemical characterization of three hamster melanoma variants--II. Glycolysis and oxygen consumption. Int J Biochem (1984) 0.86
High-resolution magic angle spinning nuclear magnetic resonance analysis of metabolic changes in melanoma cells after induction of melanogenesis. Anal Biochem (2008) 0.84
Effect of melanin on radiation response of CHO cells. Int J Radiat Biol Relat Stud Phys Chem Med (1985) 0.83
The role of NADP-dependent dehydrogenases in hydroxylation of tyrosine in hamster melanoma. Neoplasma (1983) 0.83
Biomarkers in melanoma: stage III and IV disease. Expert Rev Mol Diagn (2005) 0.83
Melanoma update: diagnostic and prognostic factors that can effectively shape and personalize management. Biomark Med (2011) 0.81
Nanomechanical analysis of pigmented human melanoma cells. Pigment Cell Melanoma Res (2013) 0.80
Prognosis of uveal melanoma based on race in 8100 patients: The 2015 Doyne Lecture. Eye (Lond) (2015) 0.79
The biological role of melanin. I. New concepts and methodical approaches. Folia Histochem Cytochem (Krakow) (1972) 0.78
Hematopoietic- and neurologic-expressed sequence 1 (Hn1) depletion in B16.F10 melanoma cells promotes a differentiated phenotype that includes increased melanogenesis and cell cycle arrest. Differentiation (2009) 0.78
Experimental ruthenium plaque therapy of amelanotic and melanotic melanomas in the hamster eye. Melanoma Res (2000) 0.78
Effect of in vitro X irradiation on pigmented and pale slices of Cloudman S91 mouse melanoma as measured by subsequent proliferation in vivo. J Natl Cancer Inst (1956) 0.78
American Joint Committee on Cancer Classification of Uveal Melanoma (Anatomic Stage) Predicts Prognosis in 7,731 Patients: The 2013 Zimmerman Lecture. Ophthalmology (2015) 0.78
Camptothecin-induced death of amelanotic and melanotic melanoma cells in different phases of cell cycle. Neoplasma (2011) 0.77
Clinical trials on chemical radiosensitization of malignant melanoma of the choroid. Ophthalmologica (1979) 0.77
Differential radiosensitivity in cultured B-16 melanoma cells following interrupted melanogenesis induced by glucosamine. Pigment Cell Res (1989) 0.77
Pathological staging of melanoma. Methods Mol Biol (2014) 0.77
Gamma radiation and MC540 photosensitization of melanoma in the hamster's eye. Melanoma Res (1999) 0.76
Rate of oxygen consumption of hamster melanoma cells as a factor influencing their radioresistance. Folia Histochem Cytochem (Krakow) (1980) 0.76
The activity of caspases in spontaneous and camptothecin-induced death of melanotic and amelanotic melanoma cell. Cancer Biol Ther (2007) 0.76